Literature DB >> 31051223

μ-Opioid receptor in the CA1 involves in tramadol and morphine cross state-dependent memory.

Saba Niknamfar1, Setareh Nouri Zadeh-Tehrani1, Mitra-Sadat Sadat-Shirazi1, Ardeshir Akbarabadi1, Afarin Rahimi-Movaghar1, Mohammad-Reza Zarrindast2.   

Abstract

In the present study, the effect of tramadol - an opioid painkiller drug with abuse potential- on amnesia and state-dependent memory and its interaction with the opioidergic system was investigated in male Wistar rats. Intra CA-1 administration of tramadol (0.5, 1, and 2 μg/rat) before training, dose-dependently decreased the learning ability in passive avoidance task. Amnesia induced by pre-train tramadol administration was significantly reversed by pre-test administration of tramadol (1 μg/rat). Pre-test administration of naltrexone (a μ-opioid receptor (MOR) antagonist) inhibited the effect of tramadol on memory retrieval. In addition, the pre-test administration of morphine (1 μg/rat, intra-CA1) also reversed memory impairment induced by pre-train tramadol administration. Although, pre-train morphine administration (1 μg/rat, intra-CA1), induced memory impairment reversed by pre-test tramadol administration (1 μg/rat, intra-CA1). In addition, the level of MOR in the hippocampus decreased in animals with memory impairment due to using tramadol in the training day. However, state-dependent retrieval using tramadol or cross state-dependent retrieval using morphine enhanced the MOR level in the hippocampus. The results of the study suggested that intra-CA1 tramadol administration induced memory impairment, improved by pre-test administration of either tramadol or morphine (MOR agonist). It could be concluded that tramadol is capable to induced state-dependent memory and also, it has a cross state-dependent memory with morphine in the hippocampus, done possibly through MOR.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Morphine; Naltrexone; State-dependent memory; Tramadol; μ-Opioid receptor

Mesh:

Substances:

Year:  2019        PMID: 31051223     DOI: 10.1016/j.neulet.2019.04.054

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  1 in total

1.  The Effect of Orexin-2 and Endocannabinoid-1 Antagonists on Neuronal Activity of Hippocampal CA1 Pyramidal Neurons in Response to Tramadol in Rats.

Authors:  Vajihe Imanpour; Parham Reisi
Journal:  Adv Biomed Res       Date:  2022-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.